Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Plus highly engineered garbage designed to fuel addiction. But it’s not impossible. I’m not paying $8 for 3lbs Mandarins; but I’ll pay $4 for 3 lbs of naval oranges.